prostate cancer
Conditions
Interventions
experimental group:PSMA radionuclide fluorescent bimodal probe for intraoperative navigation in robot-assisted laparoscopic radical prostatectomy with KangDuo Robotic System
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: a) Intermediate-risk or high-risk localized prostate cancer requiring radical prostatectomy: 1) patients with biopsis-proven prostate cancer; 2) Clinical stage T2b-T3; 3) Serum PSA >10ng/ml; 4)Gleason score 7-10 (?-? meet one of them) b) Male aged 18-75 years; c) Agree to sign the informed consent, follow the doctor's advice and follow up regularly.
Exclusion criteria
Exclusion criteria: a) Patients with the history of other malignant tumors; b) Patients unable to understand or cooperate with the PET-CT; c) Patients with cardiovascular and cerebrovascular diseases, blood system diseases, diabetes and other diseases that cannot be controlled and can not tolerate surgery; d) Patients with previous abdominal and pelvic surgery history and severe abdominal and pelvic adhesion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consistency between intraoperative fluoroscopic pelvic lymph nodes (positive or negative) and histopathological findings (benign or malignant);The consistency between the resection margin (positive or negative) of intraoperative fluorescence and the histopathological results (positive or negative).; | — |
Countries
China
Contacts
Public ContactXuesong Li
Peking University First Hospital
Outcome results
None listed